The MAPS: Motivation and Problem Solving smoking cessation program was evaluated over 12 months, with a follow-up evaluation at 18 months, in women with cervical cancer.
A presentation at the 2023 ONA Summit reviewed diagnosis and treatment recommendations for uterine, ovarian, and endometrial cancers.
Larger proportion of women with private or Medicare insurance receive diagnosis of early-stage cervical cancer.
Cervical cancer incidence has declined in recent years but have been increasing for ADC subtype at varying rates in racial and ethnic groups of women.
Compared with women aged <65 years, those aged ≥65 have lower late-stage five-year relative survival.